A study for efficacy of pharmacological thromboprophylaxis against venos thromboembolism after hepatic resection

Status

Recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR1800017385

Enrollment

Unknown

Registered

2018-07-27

Start date

2018-07-30

Completion date

Unknown

Last updated

2018-07-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Liver tumors

Interventions

Group 1:Anti-coagulation therapy was performed by 0.4ml hypodermic injection of enoxaparin sodium injection

Group 2:Routine treatment

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Preoperative liver function Child A level; 2. Physical condition ECOG grade (ZPS) 0-2, and card type (KPS) score is greater than or equal to 60; 3. The test of TEG before surgery was normal; 4. Patients voluntarily participated in this study and signed the consent form for surgery.

Exclusion criteria

Exclusion criteria: 1. Previous history of venous thromboembolism; 2. Severe cardiac, pulmonary and renal dysfunction; 3. Hormone replacement therapy is under way; 4. A history of cardiovascular and cerebrovascular events within 3 months.

Design outcomes

Primary

Measure	Time frame
The incidence of venous thromboembolism;	—

Countries

China

Contacts

Public ContactHongwei Zhang

Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University

hongweizhang88@126.com+86 13922318256

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026